Expressing Human Epidermal Growth Factor Receptor-2 (HER-2)
1 clinical trials · Condition
◉ Watch Expressing Human Epidermal Growth Factor Receptor-2 (HER-2)
| Record | Firm | Date |
|---|---|---|
| A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (NCT06577376) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2024-08-26 |
Track Expressing Human Epidermal Growth Factor Receptor-2 (HER-2) automatically
Every clearance here is in the API, with alerts when new ones post.